Neuropathic pain


Submitted: 17 February 2013
Accepted: 17 February 2013
Published: 20 February 2009
Abstract Views: 1272
PDF: 9443
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Neuropathic pain is the expression of a dysfunction or primary lesion of a nerve in the peripheral or central nervous system, or both, rather than the biological signal transmitted by the nerve following peripheral nociceptor activation. It represents about 20% of all painful syndromes, with an estimated prevalence of 1.5%, however is actual incidence is hard to pinpoint due to the difficulties encountered in distinguishing it from chronic pain, of which it represents a significant percentage, on account of the not infrequent concurrence of conditions. It is crucial to recognise the variety of symptoms with which it can present: these can be negative and positive and, in turn, motor, sensitive and autonomic. In public health terms, it is important to emphasise that the diagnosis of neuropathic pain does not in most cases require sophisticated procedures and does not therefore weigh on health expenditure. In clinical practice, a validated scale (the LANSS is mentioned) is useful for identifying patients presenting neuropathic pain symptoms. Therapy is based on three categories of medication: tricyclic antidepressants, anti-epileptics and opioids at high doses: neuropathic pain has a bad reputation for often resisting common therapeutic approaches and responding less well that nociceptor pain to monotherapy. Therapeutic strategies are all the more adequate the more they are based on symptoms and therefore on the pain generation mechanisms, although the recommendations are dictated more by expert opinions that double-blind randomised trials.

Giuseppe Re, Medicina Interna, Terapia Antalgica e Neurologia, Ospedali di Lugo e Ravenna
Virgilio Ricci, Medicina Interna, Terapia Antalgica e Neurologia, Ospedali di Lugo e Ravenna
Fabrizio Rasi, Medicina Interna, Terapia Antalgica e Neurologia, Ospedali di Lugo e Ravenna
Re, G., Ricci, V., & Rasi, F. (2009). Neuropathic pain. Emergency Care Journal, 5(1), 17–37. https://doi.org/10.4081/ecj.2009.1.17

Downloads

Download data is not yet available.

Citations